Banner - NPPA Connect

American Academy of Dermatology

Shorts

Why New Options Like Nemolizumab are Needed in Pediatric AD
0:44
Why New Options Like Nemolizumab are Needed in Pediatric AD
6 months ago
by
Lawrence Eichenfield, MD
Christopher Bunick, MD, PhD, and Reid Waldman, MD
1:30
Why Timing Is Everything With Oral Minoxidil for Pattern Hair Loss
6 months ago
by
Christopher G. Bunick, MD, PhD(+1 more)
Andrew Blauvelt, MD, MBA
0:30
40% Complete Skin Clearance With Envudeucitinib
6 months ago
by
Andrew Blauvelt, MD, MBA
Christopher Bunick, MD, PhD, and Patrick Burnett, MD, PhD
0:45
10-Minute Itch Relief for Infants With Atopic Dermatitis
6 months ago
by
Christopher G. Bunick, MD, PhD(+1 more)
Jeff Yu, MD, MS
0:41
Is It Atopic Dermatitis or Allergic Contact Dermatitis?
6 months ago
by
Jeff Yu, MD, MS
David Cotter, MD, PhD
0:55
GLP-1s: More Than Just Weight Loss for Psoriasis
6 months ago
by
Christopher G. Bunick, MD, PhD(+1 more)
Liza O'Dowd, MD
1:00
No More Needles? The Future of Psoriasis Treatment
6 months ago
by
Liza O'Dowd, MD
Christopher Bunick, MD, PhD, and Johnny Im Almirall
0:45
26 Million People Gain Access to Innovative Skin Therapy
6 months ago
by
Christopher G. Bunick, MD, PhD(+1 more)
Daniel C Butler, MD
0:46
Why Does Skin Get Itchy As We Age?
6 months ago
by
Daniel C. Butler, MD
Steven Daveluy, MD
0:30
HS Breakthrough Excitement at AAD 2026
6 months ago
by
Steven Daveluy, MD

Latest Content

Once synonymous with puberty, acne is a growing concern for adults—particularly for women—from the 20s to well into their 40s. Christopher Bunick, MD, PhD delved into treatment options for this increasing patient population at the American Academy of Dermatology 2022 Annual Meeting.

Vitiligo is challenging to treat; fortunately, continued research has led to improvements and refinements in options, giving much-needed hope to patients with this skin condition.

In this video interview, we sit down with both Jennifer Lin Hsiao, MD, FAAD, and Scott Worswick, MD, FAAD, to talk in detail about their presentation, "Hidradenitis Suppurativa and Pityriasis Rubra Pilaris: Updates on Treatments for Two Conditions that are Difficult to Manage."

In their session, “Translating Evidence into Practice: Atopic Dermatitis Guidelines,” at the current AAD annual meeting, Jonathan I. Silverberg, MD, PhD, MPH, FAAD, Peter A. Lio, MD, FAAD, Andrew Blauvelt, MD, FAAD, and Robert Sidbury, MD, MPH, FAAD, discuss updates in new therapies, clinical pearls, and potential co-morbidities.

In this video interview, we sit down with Natasha Atanaskova Mesinkovska, MD, PhD, FAAD, to discuss her 2022 AAD annual meeting presentation on alopecia areata. We dive into pipeline possibilities, what current treatments are missing, and more.